1. Home
  2. BMEA vs GLND Comparison

BMEA vs GLND Comparison

Compare BMEA & GLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biomea Fusion Inc.

BMEA

Biomea Fusion Inc.

HOLD

Current Price

$1.17

Market Cap

138.1M

Sector

Health Care

ML Signal

HOLD

GLND

Greenland Energy Company Common Stock

N/A

Current Price

$2.79

Market Cap

127.6M

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
BMEA
GLND
Founded
2017
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
138.1M
127.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BMEA
GLND
Price
$1.17
$2.79
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$9.83
N/A
AVG Volume (30 Days)
1.1M
1.0M
Earning Date
05-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
69.19
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.87
$2.55
52 Week High
$3.07
$12.80

Technical Indicators

Market Signals
Indicator
BMEA
GLND
Relative Strength Index (RSI) 35.89 37.00
Support Level $1.05 $2.62
Resistance Level $1.47 $3.36
Average True Range (ATR) 0.10 0.30
MACD -0.02 0.13
Stochastic Oscillator 15.79 23.44

Price Performance

Historical Comparison
BMEA
GLND

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.

About GLND Greenland Energy Company Common Stock

Greenland Energy Co is a Texas energy resources company focused on unlocking Greenland's vast hydrocarbon potential through the application of modern exploration technologies. It holds exclusive licenses to over 2-million acre area in the Jameson Land Basin, where its licenses cover the majority of the basin. The business model for the company is based on exploration and resource development in the frontier basins of Greenland. The company's primary focus is drilling the first wells on the project to conduct the necessary exploration, appraisal and evaluation.

Share on Social Networks: